Advances in the treatment of keloids

Journal of Drugs in Dermatology

Volumn 10, Issue 5, 2011, Pages 468-480

  Viera, Martha H ^a   Caperton, Caroline V ^a   Berman, Brian ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ALPHA2B INTERFERON; BLEOMYCIN; BOTULINUM TOXIN A; CORTICOSTEROID; DEXAMETHASONE; FLUDROXYCORTIDE; FLUOROURACIL; HYDROCORTISONE; HYDROCORTISONE ACETATE; IMIQUIMOD; INTERFERON; MEPREDNISONE; ONION EXTRACT; RAPAMYCIN; RETINOIC ACID; SILICON; SILICONE GEL; TACROLIMUS; TRIAMCINOLONE ACETONIDE; VERAPAMIL; VITAMIN D;

ATOPIC DERMATITIS; CHILL; COMPRESSION THERAPY; CRYOSURGERY; DERMATOLOGICAL PROCEDURES; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MECHANISM; ERYTHEMA; EVENING DOSAGE; EXCISION; FATIGUE; FLU LIKE SYNDROME; GENETIC PREDISPOSITION; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; HYPOPIGMENTATION; INJECTION SITE PAIN; IRRITANT DERMATITIS; KELOID; LOW LEVEL LASER THERAPY; MYALGIA; NIGHT SWEAT; OCCLUSIVE DRESSING; PHOTOSENSITIVITY; PIGMENT DISORDER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SILICONE GEL SHEETING; SKIN ATROPHY; SKIN COLOR; SKIN IRRITATION; SKIN PIGMENTATION; SKIN PRURITUS; SKIN SCAR; TANGENTIAL SHAVING; TELANGIECTASIA; THERAPY EFFECT; WOUND HEALING IMPAIRMENT; METHODOLOGY; PATHOLOGY; PATIENT EDUCATION; PRURITUS; RACE; TIME; WOUND HEALING;

CONTINENTAL POPULATION GROUPS; ERYTHEMA; HUMANS; KELOID; PATIENT EDUCATION AS TOPIC; PRURITUS; SKIN PIGMENTATION; TIME FACTORS; WOUND HEALING;

EID: 80051606042     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (151)

1. Abergel RP, Pizzurro D, Meeker CA, Lask G, Matsuoka LY, Minor RR, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. Journal of Investigative Dermatology. 1985;84:384-390. (Pubitemid 15056660)
2. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg. 1999;104(5):1435-1458. (Pubitemid 29466295)
3. Woolery-Lloyd H, Berman B. A controlled cohort study examining the onset of hypertension in black patients with keloids. Eur J Dermatol. 2002;12(6):581-582. (Pubitemid 35440800)
4. Shockman S, Paghdal KV, Cohen G. Medical and surgical management of keloids: A review. J Drugs Dermatol. 2010;9(10):1249-1257.
5. Bajaj V, Langtry JA. Surgical excision of acne keloidalis nuchae with secondary intention healing. Clin Exp Dermatol. 2008;33(1):53-55. (Pubitemid 350308522)
6. Brown JJ, Ollier W, Arscott G, Ke X, Lamb J, et al. Genetic susceptibility to Keloid scarring: SMAD gene SNP frequencies in Afro- Caribbeans. Experimental Dermatology. 2007;17,610-613. (Pubitemid 351803083)
7. Omo-Dare P. Genetic studies on keloid. J Natl Med Assoc. 1975;67:428-432.
8. Bloom D. Heredity of keloids. NY State Med J. 1956;56:511-519.
9. Marneros A G, Norris J E, Olsen B R et al. Clinical genetics of familial keloids. Arch Dermatol. 2001;137:1429-1434. (Pubitemid 33064238)
10. Russell SB, Russell JD, Trupin JM, Gayden AE, et al. Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol. 2010;130(10):2489-2496.
11. Saed GM, Ladin D, Olson J, Han X, Hou Z, et al. Analysis of p53 gene mutations in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing. Arch Dermatol. 1998;134:963-967. (Pubitemid 28385318)
12. Marneros AG, Norris JEC, Watanabe S, Reichenberger E, Olsen BR. Genome Scans Provide Evidence for Keloid Susceptibility Loci on Chromosomes 2q23 and 7p11. J Invest Dermatol. 2004;122:1126-1132. (Pubitemid 38651086)
13. Clark JA, Turner ML, Howard L, Stanescu H, et al. Description of familial keloids in five pedigrees: Evidence for autosomal dominant inheritance and phenotypic heterogeneity. BMC Dermatology. 2009;9:8.
14. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571. (Pubitemid 34815962)
15. Schaffer MR, Efron PA, Thornton FJ, Klingel K, et al. Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol. 1997;158:2375-2381. (Pubitemid 127470024)
16. Kauh YC, Rouda S, Mondragon G, Tokarek R, diLeonardo M, et al. Major suppression of pro-alpha1(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586-589. (Pubitemid 27446729)
17. Jalali M, Bayat A. Current use of steroids in management of abnormal raised skin scars. Surgeon. 2007;5:175-180.
18. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: A 10-year follow- up study. Br J Plast Surg. 1992l;45(5):374-379.
19. Lahiri A, Tsiliboti D, Gaze NR. Experience with difficult keloids. Br J Plast Surg. 2001;54(7):633-635. (Pubitemid 32982638)
20. Graham GF. Cryosurgery. Clin Plast Surg. 1993;20(1):131-147. (Pubitemid 23064001)
21. Layton AM. A review on the treatment of acne vulgaris. Int J Clin Pract. 2006;60(1):64-72. (Pubitemid 43732578)
22. Berman B, Amini S, Viera M, Valins W. Keloid and Hypertrophic Scar. eMedicine from WebMD. Available at: http://www.emedicine.com/derm/topic205.htm. Accessed November 15, 2010.
23. Fulton JE, Jr. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg. 1995;21:947-951.
24. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic Scarring and Keloids: Pathomechanisms, Current and Emerging Treatment Strategies. Mol Med. 2011;17(1-2):113-125. Epub October 5, 2010.
25. Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg. 2007;33(11):1291-1303.
26. Akaishi S, Akimoto M, Hyakusoku H, Ogawa R. The tensile reduction effects of silicone gel sheeting. Plast Reconstr Surg. 2010;126(2):109-111.
27. Gold MH, Foster TD, Adair MA, Burlison K, Lewis T. Prevention of hypertrophic scars and keloids by the prophylactic use of topical silicone gel sheets following a surgical procedure in an office setting. Dermatol Surg. 2001;27(7):641-644. (Pubitemid 32652393)
28. Berman B, Bieley HC. Keloids. J Am Acad Dermatol. 1995;33(1):117-123.
29. Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22(2):126-130. (Pubitemid 26069616)
30. Lawrence WT. In search of the optimal treatment of keloids: Report of a series and a review of the literature. Ann Plast Surg. 1991;27(2):164-178.
31. Butler PD, Longaker MT, Yang GP. Current progress in keloid research and treatment. J Am Coll Surg. 2008;206(4):731-741.
32. Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: A meta-analysis and review of the literature. Arch Facial Plast Surg. 2006;8(6):362-368. (Pubitemid 44862494)
33. Al-Attar A, Mess S, Thomassen JM, Kauffman CL, Davison SP. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117(1):286-300. (Pubitemid 44391579)
34. Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther. 2004;17(2):212-218. (Pubitemid 38656914)
35. Thomas JR, Ehlert TK. Scar revision and camouflage. Otolaryngol Clin North Am. 1990;23(5):963-973. (Pubitemid 20364779)
36. Tardy ME Jr, Thomas JR, Pashcow MS. The camouflage of cutaneous scars. Ear Nose Throat J. 1981;60(2):61-70. (Pubitemid 11186094)
37. McGillis ST, Lucas AR. Scar revision. Dermatol Clin. 1998;16(1):165-180.
38. Engrav LH, Gottlieb JR, Millard SP, Walkinshaw MD, Heimbach DM, Marvin JA. A comparison of intramarginal and extramarginal excision of hypertrophic burn scars. Plast Reconstr Surg. 1988;81(1):40-45.
39. Yang JY. Intrascar excision for persistent perioral hypertrophic scar. Plast Reconstr Surg. 1996;98(7):1200-1205.
40. Lee KK, Mehrany K, Swanson NA. Surgical revision. Dermatol Clin. 2005;23(1):141-150. (Pubitemid 40037314)
41. Berman B, Viera MH, Amini S, Huo R, Jones IS. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg. 2008;19(4):989-1006.
42. Boutli-Kasapidou F, Tsakiri A, Anagnostou E, Mourellou O. Hypertrophic and keloidal scars: An approach to polytherapy. Int J Dermatol. 2005;44:324-327. (Pubitemid 40542152)
43. Jaros E, Priborsky J, Klein L. Treatment of keloids and hypertrophic scars with cryotherapy. Acta Medica (Hradec Kralove). 1999;42(2) (suppl):61-63.
44. Yosipovitch G, et al. A comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy alone on keloids: A controlled study. J Dermatolog Treat. 2001;12:87-90. (Pubitemid 33009887)
45. Layton AM, Yip J, Cunliffe WJ. A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br J Dermatol. 1994;130(4):498-501. (Pubitemid 24204671)
46. Shepherd JP, Dawber RP. The response of keloid scars to cryosurgery. Plast Reconstr Surg. 1982;70(6):677-682. (Pubitemid 13223586)
47. Zouboulis CC, Blume U, Buttner P, Orfanos CE. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol. 1993;129(9):1146-1151. (Pubitemid 23272094)
48. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19(6):529-534. (Pubitemid 24173970)
49. Mustoe TA, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560-571. (Pubitemid 34815962)
50. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg. 1999;25(8):631-638. (Pubitemid 29383470)
51. Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111(6):1841-1852. (Pubitemid 36532336)
52. Sharpe D. Of apples and oranges, file drawers and garbage: Why validity issues in meta-analysis will not go away. Clin Psychol Rev. 1997;17:881-901. (Pubitemid 28027416)
53. Berman B. Biological agents for controlling excessive scarring. Am J Clin Dermatol. 2010;11(suppl 1):31-34.
54. Novak N, Yu CF, Bieber T, et al. Toll-like receptor 7 agonists and skin. Drug News Perspect. 2008;21:158-165 (Pubitemid 351809139)
55. Schon MP, Schon M. Imiquimod: Mode of action. Br J Dermatol. 2007;157 (suppl. 2):8-13. (Pubitemid 350179622)
56. Mrowietz U, Seifert O. Keloid scarring: New treatments ahead. Actas Dermosifiliogr. 2009;100(suppl 2):75-83.
57. Martin-Garcia RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: Results of an open-label, pilot study. Dermatol Surg. 2005;31:1394-1398.
58. Smith P, Mosiello G, Deluca L, Ko F, Maggi S, et al. TGF-beta2 activates proliferative scar fibroblasts. J Surg Res. 1999;82(2):319-323. (Pubitemid 29394140)
59. Chuangsuwanich A, Gunjittisomram S. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids. J Med Assoc Thai. 2007;90(7):1363-1367. (Pubitemid 47414510)
60. Viera MH, Amini S, Konda S, Berman B. Do postsurgical interventions optimize ultimate scar cosmesis. G Ital Dermatol Venereol. 2009;144(3):243-257.
61. Valerón-Almazán P, Dehesa-García L, Vilar-Alejo J, Domínguez-Silva J, Gómez-Duaso J, Carretero-Hernández G. Surgical treatment of relapsing keloid of the pinna by fillet flap. Actas Dermosifiliogr. 2010;101(3):235-241.
62. Cacao FM, Tanaka V, Messina MC. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg. 2009;35:629-633.
63. Berman B, Duncan MR. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol. 1989;21:694-702. (Pubitemid 19251728)
64. Berman B, Flores F. Interferons. In: Wolverton SE, ed. Comprehensive Dermatologic Drug Therapy. Philadelphia, PA: WB Saunders; 2001:339-357.
65. Torkian BA, Yeh AT, Engel R, Sun CH, et al. Modeling aberrant wound healing using tissue-engineered skin constructs and multiphoton microscopy. Arch Facial Plast Surg. 2004;6(3):180-187.
66. Conejo-Mir JS, Corbi R, Linares M. Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids. J Am Acad Dermatol. 1998;39(6):1039-1040. (Pubitemid 28547751)
67. Lee JH, Kim SE, Lee AY. Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol. 2008;47(2):183-186.
68. Poochareon VN, Berman B. New therapies for the management of keloids. J Craniofac Surg. 2003;14(5):654-657.
69. Davison SP, Mess S, Kauffman LC, et al. Ineffective treatment of keloids with interferon alpha-2b. Plast Reconstr Surg. 2006;117:247-252. (Pubitemid 44391573)
70. Espinassouze F, Heid E, Grosshans E. Treatment of keloid by intralesional injections of interferon alfa-2B. Ann Dermatol Venereol. 1993;120:629-630.
71. Wong TW, Chiu HC, Yip KM. Intralesional interferon alpha-2b has no effect in the treatment of keloids. Br J Dermatol. 1994;130:683-685.
72. Al-Khawajah MM. Failure of interferon-alpha 2b in the treatment of mature keloids. Int J Dermatol. 1996;35:515-517. (Pubitemid 26233406)
73. Uppal RS, Khan U, Kakar S, Talas G, et al. The effects of a single dose of 5-fluorouracil on keloid scars: A clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg. 2001;108(5):1218-1224. (Pubitemid 32953059)
74. Wendling J, Marchand A, Mauviel A, et al. 5-fluorouracil blocks transforming growth factor-beta-induced alpha 2 type I collagen gene (COL1A2) expression in human fibroblasts via c-Jun NH2-terminal kinase/activator protein-1 activation. Mol Pharmacol. 2003;64:707-713. (Pubitemid 37048575)
75. Shridharani SM, Magarakis M, Manson PN, Singh NK, et al. The emerging role of antineoplastic agents in the treatment of keloids and hypertrophic scars: A review. Ann Plast Surg. 2010;64(3):355-361.
76. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25(3):224-232. (Pubitemid 29146991)
77. Apikian M, Goodman G. Intralesional 5-fluorouracil in the treatment of keloid scars. Australas J Dermatol. 2004;45(2):140-143. (Pubitemid 38607932)
78. Uppal RS, Khan U, Kakar S, Talas G, Chapman P, McGrouther AD. The effects of a single dose of 5-fluorouracil on keloid scars: A clinical trial of timed wound irrigation after extralesional excision. Plast Reconstr Surg. 2001;108(5):1218-1224. (Pubitemid 32953059)
79. Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal and hypertrophic sternotomy scars: Comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138(9):1149-1155. (Pubitemid 35025686)
80. Huang L, Wong YP, Cai YJ, Lung I, et al. Low-dose 5-fluorouracil induces cell cycle G2 arrest and apoptosis in keloid fibroblasts. Br J Dermatol. 2010;163(6):1181-1185.
81. Kontochristopoulos G, Stefanaki C, Panagiotopoulos A, et al. Intralesional 5-fluorouracil in the treatment of keloids: An open clinical and histopathologic study. J Am Acad Dermatol. 2005;52:474-479.
82. Nanda S, Reddy BS. Intralesional 5-fluorouracil as a treatment modality of keloids. Dermatol Surg. 2004;30(1):54-56; discussion 56-57.
83. Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-Fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006;32(7):907-915. (Pubitemid 44034368)
84. Haurani MJ, Foreman K, Yang JJ, et al. 5-Fluorouracil treatment of problematic scars. Plast Reconstr Surg. 2009;123:139-151.
85. Goldan O, Weissman O, Regev E, et al. Treatment of postdermabrasion facial hypertrophic and keloid scars with intralesional 5-Fluorouracil injections. Aesthetic Plast Surg. 2008;32:389-392.
86. Alster TS, Handrick C. Laser treatment of hypertrophic scars, keloids, and striae. Semin Cutan Med Surg. 2000;19:287-292. (Pubitemid 32042983)
87. Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg. 1995;21(8):685-687.
88. Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: A review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46(suppl 2):63S-97S.
89. Manuskiatti W, Wanitphakdeedecha R, Fitzpatrick RE. Effect of pulse width of a 595-nm flashlamp-pumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars. Dermatol Surg. 2007;33(2):152-161. (Pubitemid 46208105)
90. Chan HH, et al. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in Chinese persons. Dermatol Surg. 2004;30:987-994. (Pubitemid 38890906)
91. Conologue TD, Norwood C. Treatment of surgical scars with the cryogen-cooled 595 nm pulsed dye laser starting on the day of suture removal. Dermatol Surg. 2006;32(1):13-20.
92. Alam M, Pon K, Van Laborde S, Kaminer MS, et al. Clinical effect of a single pulsed dye laser treatment of fresh surgical scars: Randomized controlled trial. Dermatol Surg. 2006;32(1):21-25.
93. Abergel RP, Meeker CA, Lam TS, Dwyer RM, Lesavoy MA, Uitto J. Control of connective tissue metabolism by lasers: Recent developments and future prospects. J Am Acad Dermatol. 1984;11(6):1142-1150. (Pubitemid 15210496)
94. Sherman R, Rosenfeld H. Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg. 1988;21(3):231-235.
95. Elsaie ML, Choudhary S. Lasers for scars: A review and evidence-based appraisal. J Drugs Dermatol. 2010;9(11):1355-1362.
96. Reish RG, Erksson E. Scar treatment: Preclinical and clinical studies. J AM Coll Surg. 2008;206(4):719-730.
97. Hambleton J, Shakespeare PG, Pratt BJ. The progress of hypertrophic scars monitored by ultrasound measurements of thickness. Burns. 1992;18(4):301-307.
98. Nowak KC, McCormack M, Koch RJ. The effect of superpulsed carbon dioxide laser energy on keloid and normal dermal fibroblast secretion of growth factors: A serum-free study. Plast Reconstr Surg. 2000;105(6):2039-2048. (Pubitemid 30244008)
99. Norris JE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg. 1991;87(1):44-49.
100. Berman B, Villa A, Ramirez C. Novel opportunities in the treatment and prevention of scarring. J Cutan Med Surg. 2005;8(3):32-36.
101. Eberlein A, Schepler H, Spilker G, Altmeyer P, et al. Erbium:YAG laser treatment of post-burn scars: Potentials and limitations. Burns. 2005;31(1):15-24. (Pubitemid 40082644)
102. Cheng ET, Nowak KC, Koch RJ. Effect of blended carbon dioxide and erbium:YAG laser energy on preauricular and ear lobule keloid fibroblast secretion of growth factors: A serum-free study. Arch Facial Plast Surg. 2001;3(4):252-257.
103. Bowes LE, Nouri K, Berman B, Jimenez G, et al. Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: A comparative study. Dermatol Surg. 2002;28(8):714-719. (Pubitemid 34913281)
104. Tredget EE, Nedelec B, Scott PG, Ghahary A. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am. 1997;77:701-730. (Pubitemid 27256042)
105. Apfelberg DB, Maser MR, Lash H. The use of epidermis over a keloid as an autograft after resection of the keloid. J Dermatol Surg. 1976;2(5):409-411.
106. Klumpar DI, Murray JC, Anscher M. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol. 1994;31:225-231. (Pubitemid 24242858)
107. Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Post-operative electron-beam irradiation therapy for keloids and hypertrophic scars: Retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111:547-553. (Pubitemid 36182286)
108. Ragoowansi R, Cornes PG, Moss AL, Glees JP. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg. 2003;111:1853-1859. (Pubitemid 36532337)
109. Panizzon RG. Dermatologic radiotherapy. Hautarzt. 2007;58:701-710.
110. Guix B, et al. Treatment of keloids by high-dose-rate brachytherapy: A seven-year study. Int J Radiat Oncol Biol Phys. 2001;50:67-172.
111. Reish RG, Eriksson E. Scar treatments: Preclinical and clinical studies. J Am Coll Surg. 2008;206:719-730.
112. Borok TL, Bray M, Sinclair I, et al. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys. 1998;15:836-870.
113. Norris JE. Superficial x-ray therapy in keloid management: A retrospective study of 24 cases and literature review. Plast Reconstr Surg. 1995;95(6):1051-1055.
114. Escarmant P, Zimmerman S, Amar A, et al. The treatment of 783 keloid scars by iridium 192 interstitial irradiation after surgical excision. Int J Radiat Oncol Biol Phys. 1993;26:245-251. (Pubitemid 23156971)
115. Levitt WM, Gillies H. Radiotherapy in the prophylaxis and treatment of keloids. Lancet. 1942;1:440-443.
116. Cornbleet T. Treatment of keloids with hyaluronidase. JAMA. 1954;134:1161-1163.
117. Sclafani AP, Gordon L, Chadha M, Romo T 3rd. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: A randomized, prospective study and review of the literature. Dermatol Surg. 1996;22(6):569-574. (Pubitemid 26200115)
118. Guix B, Henriquez I, Andres A, et al. Treatment of keloids by high-dose- rate brachytherapy: A seven-year study. Int J Radiat Oncol Biol Phys. 2001;50:167-172.
119. Kovalic JJ, Pérez CA. Radiationtherapy following keloidectomy: A 20-year experience. Int J Radiat Oncol Biol Phys. 1989;17:77-80. (Pubitemid 19173241)
120. Bennett JM, Reich SD. Bleomycin. Ann Intern Med. 1979;90:945-948. (Pubitemid 9229633)
121. Vernole P, Tedeschi B, Caporossi D, Maccarrone M, Melino G, Annicchiarico-Petruzzelli M. Induction of apoptosis by bleomycin in resting and cycling human lymphocytes. Mutagenesis. 1998;13(3):209-215. (Pubitemid 28243153)
122. España A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27(1):23-27. (Pubitemid 32107611)
123. Bodokh I, Brun P. Treatment of keloid with intralesional bleomycin. Ann Dermatol Venereol. 1996;123(12):791-794.
124. Saray Y, Gulec AT. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: A preliminary study. Int J Dermatol. 2005;44(9):777-784. (Pubitemid 41301018)
125. Naeini FF, Najafian J, Ahmadpour K. Bleomycin tattooing as a promising therapeutic modality in large keloids and hypertrophic scars. Dermatol Surg. Aug 2006;32(8):1023-1029; discussion 1029-1030.
126. Aggarwal H, Saxena A, Lubana PS, et al. Treatment of keloids and hypertrophic scars using bleomycin. J Cosmet Dermatol. 2008;7:43-49. (Pubitemid 351228166)
127. Copcu E, Sivrioglu N, Oztan Y. Combination of surgery and intralesional verapamil injection in the treatment of the keloid. J Burn Care Rehabil. 2004;25:1-7. (Pubitemid 38120353)
128. Skaria AM. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2004;209(1):71. (Pubitemid 39179113)
129. D'Andrea F, Brongo S, Ferraro G, Baroni A. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2002;204(1):60-62. (Pubitemid 34136816)
130. Lawrence WT. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg. 1996;37(2):167-169. (Pubitemid 126424085)
131. Margaret Shanthi FX, Ernest K, Dhanraj P. Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. Indian J Dermatol Venereol Leprol. 2008;74(4):343-348.
132. Abergel RP, Meeker CA, Oikarinen H, Oikarinen AI, Uitto J. Retinoid modulation of connective tissue metabolism in keloid fibroblast cultures. Arch Dermatol. 1985;121:632-635. (Pubitemid 15062716)
133. Oikarinen H, Oikarinen AI, Tan EM, et al. Modulation of procollagen gene expression by retinoids. Inhibition of collagen production by retinoic acid accompanied by reduced type I procollagen messenger ribonucleic acid levels in human skin fibroblast cultures. J Clin Invest. 1985;75:1545-1553. (Pubitemid 15041447)
134. Janssen de Limpens AM. The local treatment of hypertrophic scars and keloids with topical retinoic acid. Br J Dermatol. 1980;103:319-323.
135. Panabiere-Castaings MH. Retinoic acid in the treatment of keloids. J Dermatol Surg Oncol. 1988;14:1275-1276. (Pubitemid 19000514)
136. Hansen DA. Treatment of hypertrophic scars with retinoic acid. S Afr Med J. 1979;56:1114. (Pubitemid 10142117)
137. Viera MH, Amini S, Valins W, Berman B. Innovative therapies in the treatment of keloids and hypertrophic scars. J Clin Aesthet Dermatol. 2010;3(5):20-26.
138. Kim A, DiCarlo J, Cohen C, et al. Are keloids really "gli- loids"?: Highlevel expression of gli-1 oncogene in keloids. J Am Acad Dermatol. 2001;45(5):707-711. (Pubitemid 33032567)
139. Ong CT, Khoo YT, Mukhopadhyay A, et al. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp Dermatol. 2007;16:394-404. (Pubitemid 46585367)
140. Zhibo X, Miaobo Z. Intralesional botulinum toxin type A injection as a new treatment measure for keloids. Plast Reconstr Surg. 2009;124(5):275-277.
141. Xiao Z, Zhang F, Cui Z. Treatment of hypertrophic scars with intralesional botulinum toxin type A injections: A preliminary report. Aesthetic Plast Surg. 2009;33(3):409-412.
142. Venus MR. Use of botulinum toxin type A to prevent widening of facial scars. Plast Reconstr Surg. 2007;119(1):423-424; author reply 424.
143. Uyesugi B, Lippincott B, Dave S. Treatment of a painful keloid with botulinum toxin type A. Am J Phys Med Rehabil. 2010;89(2):153-155.
144. Hosnuter M, Payasli C, Isikdemir A, Tekerekoglu B. The effects of onion extract on hypertrophic and keloid scars. J Wound Care. 2007;16:251-254.
145. Saulis AS, Mogford JH, Mustoe TA. Effect of Mederma on hypertrophic scarring in the rabbit ear model. Plast Reconstr Surg. 2002;110(1):177-183. (Pubitemid 34686266)
146. Koc E, Arca E, Surucu B, Kurumlu Z. An open, randomized, controlled, comparative study of the combined effect of intralesional triamcinolone acetonide and onion extract gel and intralesional triamcinolone acetonide alone in the treatment of hypertrophic scars and keloids. Dermatol Surg. 2008;34(11):1507-1514.
147. Perez OA, Viera MH, Patel JK, Konda S, Amini S, Huo R, Zell D, Tadicherla S, Berman B. A comparative study evaluating the tolerability and efficacy of two topical therapies for the treatment of keloids and hypertrophic scars. J Drugs Dermatol. 2010;9(5):514-518.
148. Baumann LS, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg. 1999;25:311-315. (Pubitemid 29191320)
149. Khoosal D, Goldman R. Vitamin E for treating children's scars. Does it help reduce scarring? Can Fam Physician. 2006;52:855-856. (Pubitemid 44406033)
150. Zhang GY, Cheng T, Luan Q, Liao T, et al. Vitamin D: A novel therapeutic approach for keloid, an in vitro analysis. Br J Dermatol. 2010;164 (4):729-737.
151. Ogawa R. The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. Plastic and Reconstructive Surgery. 2010;125(2):557-568.